Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 862106

Adamantane in Drug Delivery Systems and Surface Recognition


Štimac, Adela; Šekutor, Marina; Mlinarić-Majerski, Kata; Frkanec, Leo; Frkanec, Ruža
Adamantane in Drug Delivery Systems and Surface Recognition // Molecules, 22 (2017), 2; 297, 14 doi:10.3390/molecules22020297 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 862106 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Adamantane in Drug Delivery Systems and Surface Recognition

Autori
Štimac, Adela ; Šekutor, Marina ; Mlinarić-Majerski, Kata ; Frkanec, Leo ; Frkanec, Ruža

Izvornik
Molecules (1420-3049) 22 (2017), 2; 297, 14

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
adamantane ; targeted drug delivery ; liposomes ; surface recognition ; cyclodextrins ; dendrimers

Sažetak
The adamantane moiety is widely applied in design and synthesis of new drug delivery systems and in surface recognition studies. This review focuses on liposomes, cyclodextrins, and dendrimers based on or incorporating adamantane derivatives. Our recent concept of adamantane as an anchor in the lipid bilayer of liposomes has promising applications in the field of targeted drug delivery and surface recognition. The results reported here encourage the development of novel adamantane-based structures and self-assembled supramolecular systems for basic chemical investigations as well as for biomedical application.

Izvorni jezik
Engleski

Znanstvena područja
Kemija



POVEZANOST RADA


Projekti:
HRZZ-IP-2013-11-7387 - Supramolekulska sinteza samo-organizirajućih funkcionalnih nanomaterijala i kompleksnih kemijskih sustava (SInFONIA) (Frkanec, Leo, HRZZ - 2013-11) ( CroRIS)

Ustanove:
Institut "Ruđer Bošković", Zagreb

Profili:

Avatar Url Leo Frkanec (autor)

Avatar Url Kata Majerski (autor)

Avatar Url Ruža Frkanec (autor)

Avatar Url Adela Štimac (autor)

Avatar Url Marina Šekutor (autor)

Poveznice na cjeloviti tekst rada:

doi www.mdpi.com fulir.irb.hr

Citiraj ovu publikaciju:

Štimac, Adela; Šekutor, Marina; Mlinarić-Majerski, Kata; Frkanec, Leo; Frkanec, Ruža
Adamantane in Drug Delivery Systems and Surface Recognition // Molecules, 22 (2017), 2; 297, 14 doi:10.3390/molecules22020297 (međunarodna recenzija, pregledni rad, znanstveni)
Štimac, A., Šekutor, M., Mlinarić-Majerski, K., Frkanec, L. & Frkanec, R. (2017) Adamantane in Drug Delivery Systems and Surface Recognition. Molecules, 22 (2), 297, 14 doi:10.3390/molecules22020297.
@article{article, author = {\v{S}timac, Adela and \v{S}ekutor, Marina and Mlinari\'{c}-Majerski, Kata and Frkanec, Leo and Frkanec, Ru\v{z}a}, year = {2017}, pages = {14}, DOI = {10.3390/molecules22020297}, chapter = {297}, keywords = {adamantane, targeted drug delivery, liposomes, surface recognition, cyclodextrins, dendrimers}, journal = {Molecules}, doi = {10.3390/molecules22020297}, volume = {22}, number = {2}, issn = {1420-3049}, title = {Adamantane in Drug Delivery Systems and Surface Recognition}, keyword = {adamantane, targeted drug delivery, liposomes, surface recognition, cyclodextrins, dendrimers}, chapternumber = {297} }
@article{article, author = {\v{S}timac, Adela and \v{S}ekutor, Marina and Mlinari\'{c}-Majerski, Kata and Frkanec, Leo and Frkanec, Ru\v{z}a}, year = {2017}, pages = {14}, DOI = {10.3390/molecules22020297}, chapter = {297}, keywords = {adamantane, targeted drug delivery, liposomes, surface recognition, cyclodextrins, dendrimers}, journal = {Molecules}, doi = {10.3390/molecules22020297}, volume = {22}, number = {2}, issn = {1420-3049}, title = {Adamantane in Drug Delivery Systems and Surface Recognition}, keyword = {adamantane, targeted drug delivery, liposomes, surface recognition, cyclodextrins, dendrimers}, chapternumber = {297} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font